APOE and metabolic dysfunction-associated steatotic liver disease: We previously reported a novel metabolically healthy obesity mouse model, in which atherosclerosis is decreased due to proinflammatory microRNA-155 (miR155) deficiency in apolipoprotein E deficient (ApoE–/–) mice but NAFLD development is sustained (10).